J. Wingard

发表

Mismanaging the gift of life: noncompliance in the context of adult stem cell transplantation

M. Bishop, J. Rodrigue, J. Wingard, 2002, Bone Marrow Transplantation.

Monitoring vital signs in a bone marrow transplant unit: are they needed in the middle of the night?

J. Wingard, Shalini Sharda, J. Carter, 2001, Bone Marrow Transplantation.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy

Julia M. Barbarino, T. Klein, H. McLeod, 2017, Clinical pharmacology and therapeutics.

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

J. Wingard, P. Mehta, V. Reddy, 2002, Bone Marrow Transplantation.

Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab

J. Wingard, J. Graham-Pole, S. Skoda-Smith, 2001, Bone Marrow Transplantation.

Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight

M. Sugrue, J. Wingard, P. Kubilis, 1999, Bone Marrow Transplantation.

Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic?

M. Norkin, H. Lazarus, J. Wingard, 2013, Bone Marrow Transplantation.

Successful salvage using mismatched umbilical cord blood transplant in an adult with recurrent acute myelogenous leukemia failing autologous peripheral blood progenitor cell transplant: a case history and review

J. Wingard, J. Moreb, F. Weeks, 1998, Bone Marrow Transplantation.

Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation

S. Dix, H. Holland, I. Redei, 1997, Bone Marrow Transplantation.

Clinical guide to fertility preservation in hematopoietic cell transplant recipients

M. Sorror, J. Wingard, J. Pidala, 2014, Bone Marrow Transplantation.

Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses

J. Wingard, 1997, Bone Marrow Transplantation.

A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation

T. Small, M. Petrarca, K. Miller, 2001, Bone Marrow Transplantation.

Biosensors with Fiberoptics

Donald L. Wise, D. Wise, Jr. Wingard, 1991, Contemporary Instrumentation and Analysis.

Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

J. Wingard, B. Andersson, H. Fernandez, 2000, Bone Marrow Transplantation.

Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions

H. Holland, I. Redei, J. Wingard, 1997, Bone Marrow Transplantation.

Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation

J. Wingard, J. Graham-Pole, P. Mehta, 1999, Bone Marrow Transplantation.

Practical considerations in the use of tacrolimus for allogeneic marrow transplantation

J. Uberti, D. Przepiorka, J. Wingard, 1999, Bone Marrow Transplantation.

Tacrolimus pharmacokinetics in BMT patients

J. Fay, J. Wingard, R. Nash, 1998, Bone Marrow Transplantation.

Acquiescence to adjunctive experimental therapies may relate to psychological distress: pilot data from a bone marrow transplant center

J. Rodrigue, J. Wingard, P. Mehta, 2000, Bone Marrow Transplantation.

Gastroparesis following bone marrow transplantation

J. Manivel, J. Wingard, D. Eagle, 2001, Bone Marrow Transplantation.

Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide

M. Norkin, J. Wingard, S. Glover, 2017, Bone Marrow Transplantation.

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.

J. Armitage, J. Vose, E. Montserrat, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation

P. Burke, H. Braine, P. Burke, 1988 .

Myeloma Autologous stem cell transplantation in multiple myeloma patients o60 vs X60 years of age

D. Weisdorf, J. Wingard, D. Vesole, 2003 .